ID Source | ID |
---|---|
PubMed CID | 5464186 |
CHEMBL ID | 2107032 |
SCHEMBL ID | 120834 |
MeSH ID | M0163428 |
Synonym |
---|
pentamorphone |
rx-77989 |
a-4492 , |
D05416 |
68616-83-1 |
pentamorphone (usan/inn) |
rx77989 |
pentamorphona [inn-spanish] |
mm4487b4mw , |
7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methyl-14-(pentylamino)morphinan-6-one |
unii-mm4487b4mw |
morphinan-6-one, 7,8-didehydro-4,5-epoxy-3-hydroxy-17-methyl-14-(pentylamino)-, (5alpha)- |
pentamorphona |
pentamorphonum |
pentamorphonum [inn-latin] |
rx 77989 |
pentamorphone [usan:inn] |
14b-n-pentylaminomorphinone |
CHEMBL2107032 |
SCHEMBL120834 |
pentamorphone [inn] |
morphinan-6-one, 7,8-didehydro-4,5-epoxy-3-hydroxy-17-methyl-14-(pentylamino)-, (5.alpha.)- |
pentamorphone [usan] |
pentamorphone [mart.] |
(4r,4as,7ar,12br)-9-hydroxy-3-methyl-4a-(pentylamino)-2,3,4,4a-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7ah)-one |
Q7165029 |
DTXSID901018235 |
pentamorphone; rx 77989;a 4492 |
penomorphone |
(4r,4as,7ar,12br)-9-hydroxy-3-methyl-4a-(pentylamino)-2,4,7a,13-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one |
Pentamorphone is a novel, potent opiate with rapid onset and short duration of action that has been reported to produce analgesia with limited depression of ventilation. It appears to be an analgesic with clinically tolerable side effects in the range 0.12 to 0.24 microgram.kg-1.
Excerpt | Reference | Relevance |
---|---|---|
"Pentamorphone is a new, highly potent opioid reported to have minimal cardiovascular effects in humans and a high therapeutic index in animals. " | ( Pharmacodynamics of pentamorphone during coronary artery bypass grafting in humans. Falinski, BA; Hug, CC; Klochany, A; Sebel, PS, 1992) | 2.05 |
"Pentamorphone is a novel, potent opiate with rapid onset and short duration of action that has been reported to produce analgesia with limited depression of ventilation. " | ( Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone. Afifi, MS; Camporesi, EM; Cohen, NA; Glass, PS; Shook, JE, 1990) | 1.96 |
"Pentamorphone appears to be an analgesic with clinically tolerable side effects in the range 0.12 to 0.24 microgram.kg-1 that merits further evaluation under clinical conditions." | ( Evaluation of pentamorphone in humans: a new potent opiate. Camporesi, EM; Glass, PS; Quill, T; Reves, JG; Shafron, D, 1989) | 1.36 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.19) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 4 (50.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (50.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |